CREB1 and thyroid gland disorder: This fusion reduces the CCDC6-mediated inhibition of CREB1, resulting in increased CREB1 activity and the upregulation of its target genes, such as AREG and cyclin A, thereby promoting thyroid tumorigenesis [59].